Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
54.08 USD   +1.18%
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperform Rating
MT
11/03Intra-Cellular Therapies Reports Narrower Q3 Loss, Higher Revenue; Shares Jump
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INTRA-CELLULAR THERAPIES, INC.
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperfor..
MT
11/03Intra-Cellular Therapies Reports Narrower Q3 Loss, Higher Revenue; Shares Jump
MT
11/03Transcript : Intra-Cellular Therapies, Inc., Q3 2022 Earnings Call, Nov 03, 2..
CI
11/03Intra-cellular : Q3 Earnings Snapshot
AQ
11/03Intra-Cellular Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/03Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q3 Revenue $71.9M
MT
11/03Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corp..
AQ
10/27Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call a..
AQ
10/06RBC Cuts Price Target on Intra-Cellular Therapies to $67 From $70, Maintains Outperform..
MT
09/26Insider Sell: Intra-Cellular Therapies
MT
08/22Goldman Sachs Cuts Intra-Cellular Therapies to Neutral From Buy, Price Target to $49 Fr..
MT
08/15Insider Sell: Intra-Cellular Therapies
MT
08/11Mizuho Securities Adjusts Intra-Cellular Therapies' Price Target to $72 From $75, Keeps..
MT
08/10Needham Adjusts Intra-Cellular Therapies' Price Target to $67 from $65, Keeps Buy Ratin..
MT
More most relevant news
All news about INTRA-CELLULAR THERAPIES, INC.
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperfor..
MT
11/03Intra-Cellular Therapies Reports Narrower Q3 Loss, Higher Revenue; Shares Jump
MT
11/03Transcript : Intra-Cellular Therapies, Inc., Q3 2022 Earnings Call, Nov 03, 2..
CI
11/03Intra-cellular : Q3 Earnings Snapshot
AQ
11/03INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
11/03Intra-Cellular Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/03Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
11/03Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q3 Revenue $71.9M
MT
11/03Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corp..
AQ
More news
News in other languages on INTRA-CELLULAR THERAPIES, INC.
11/03Intra-Cellular Therapies annonce une perte plus étroite au troisième trimestre et une a..
11/03Intra-Cellular Therapies, Inc. annonce ses résultats pour le troisième trimestre et les..
08/15Vente d'initiés : Intra-Cellular Therapies
08/09La perte nette d'Intra-Cellular Therapies au deuxième trimestre se creuse, mais les rev..
08/09Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES annonce un chiffre d'affaires de 55,6 mi..
08/09Intra-Cellular Therapies, Inc. annonce ses résultats pour le deuxième trimestre et le s..
05/10Mise à jour sectorielle : Les actions du secteur de la santé por..
05/10Mise à jour sectorielle : Les actions du secteur de la santé son..
05/10La perte du 1er trimestre d'Intra-Cellular Therapies se creuse ; les revenus augmentent..
05/10La perte du premier trimestre d'Intra-Cellular Therapies s'étend ; les revenus augmente..
More news
Analyst Recommendations on INTRA-CELLULAR THERAPIES, INC.
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperfor..
MT
10/06RBC Cuts Price Target on Intra-Cellular Therapies to $67 From $70, Maintains Outperform..
MT
08/22Analyst recommendations: Snowflake, Vipshop, UIta Beauty, VF, Ad..
MS
08/22Goldman Sachs Cuts Intra-Cellular Therapies to Neutral From Buy, Price Target to $49 Fr..
MT
08/11Mizuho Securities Adjusts Intra-Cellular Therapies' Price Target to $72 From $75, Keeps..
MT
More recommendations
Press releases
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/03Intra-cellular : Q3 Earnings Snapshot
AQ
11/03INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
11/03Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
11/03Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corp..
AQ
More press releases
Upcoming event on INTRA-CELLULAR THERAPIES, INC.